Latest News

Rapid-acting antidepressant for treatment-resistant depression: New insights

Researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression. The researchers found that by blocking NMDA receptors with the drug ketamine, they could elicit rapid antidepressant effects in patients with treatment-resistant depression. Ketamine was developed as an anesthetic, but is better known publicly for its abuse as the party drug Special K. Researchers are now seeking alternatives because ketamine can produce side effects that include hallucinations and the potential for abuse -- limiting its utility as an antidepressant.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Vitamin D deficiency increases poor brain function after cardiac arrest by sevenfold

  • I have anxiety, why is my doctor prescribing an antipsychotic? New drug naming system unveiled

  • Women more likely to develop anxiety and depression after heart attack

  • Gene duplications associated with autism evolved recently in human history

  • Research reveals likelihood, onset of multiple sclerosis diagnosis among patients with inflammatory eye disease

  • Eating breakfast increases brain chemical involved in regulating food intake, cravings

  • Using feminist theory to understand male rape

  • YouTube as peer support for severe mental illness

  • Women driven by status, wealth rather than wanting babies, study suggests

  • Change your walking style, change your mood

  •